Answer
Risperdal Consta (risperidone prolonged-release injection) is contraindicated in people with hypersensitivity to risperidone or any excipient listed in section 6.1.
Sources for this answer
- RISPERDAL CONSTA 25 mg powder and solvent for prolonged-release suspension for injectionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 41Document updated
Sources checked